The CDC's Learn the Signs Act Early team is excited about the new app launched by Childstones.org.
The Story Behind The (re)brand.
Recognizing April as National Parkinson's Awareness Month
Continued funding supports collaboration on portable medical diagnostics of heart disease in primary care settings.
Rapid irrigant delivery, coupled with user-selected quantifiable pressure, revolutionizes wound management for optimal healing outcomes.
Company establishes Executive Committee to guide strategic growth initiatives
Compass digital pressure transducers deliver, quick, easy and precise pressure measurements and monitoring.
Same Day Results for 14 of the Most Common Causes of Infectious Diarrhea.
For centuries pathologists have relied on the microscopic examination of tumors to distinguish between atypical moles and melanoma. By analyzing the level of proteins within mole cells, mass spectrometry can aid in the diagnosis of atypical moles. In this study, mass spectrometry correlated better than the gold standard of histologic examination to determine if an atypical mole was in fact benign or a melanoma. Early diagnosis of melanoma is critical to cure and long term survival.
R-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases.
Invents unveils the "Emergency Medical Assist" which provides security for vehicle drivers when a health problem becomes a risk factor.
Future Market Insights has announced the addition of the "Hepatitis B Diagnostic Test Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Geneticure will explain results from a retrospective study that demonstrate that the patented Geneticure Hypertension Panel significantly reduces the time to achieve optimal blood pressure control and can reduce the number of clinic visits for patients being treated for hypertension.
TeleMED Diagnostic Management (TeleMED) is pleased to announce that its signature cloud-based ViTELflo application is now cross-browser compatible with the full suite of widely-used browsers, including Windows Internet Explorer 7+/Microsoft Edge, Mozilla Firefox, Google Chrome, Safari and Opera.